COSCIENS Biopharma Inc. Quarterly Liabilities in USD from Q4 2016 to Q1 2024

Taxonomy & unit
ifrs-full: USD
Summary
COSCIENS Biopharma Inc. quarterly Liabilities history and growth rate from Q4 2016 to Q1 2024.
  • COSCIENS Biopharma Inc. Liabilities for the quarter ending March 31, 2024 was $18.8M, a 6.24% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $18.8M -$1.25M -6.24% Mar 31, 2024 6-K 2024-05-16
Q4 2023 $18.8M -$1.43M -7.06% Dec 31, 2023 20-F/A 2024-07-17
Q3 2023 $16.2M -$980K -5.7% Sep 30, 2023 6-K 2023-11-09
Q2 2023 $17.4M -$127K -0.72% Jun 30, 2023 6-K 2023-08-09
Q1 2023 $20.1M -$3.11M -13.4% Mar 31, 2023 6-K 2023-05-09
Q4 2022 $20.3M -$6.87M -25.3% Dec 31, 2022 20-F/A 2024-07-17
Q3 2022 $17.2M -$4.93M -22.3% Sep 30, 2022 6-K 2022-11-03
Q2 2022 $17.5M -$5.47M -23.8% Jun 30, 2022 6-K/A 2022-08-04
Q1 2022 $23.2M +$345K +1.51% Mar 31, 2022 6-K 2022-05-11
Q4 2021 $27.1M +$3.32M +14% Dec 31, 2021 20-F/A 2024-02-15
Q3 2021 $22.1M +$4.99M +29.2% Sep 30, 2021 6-K 2021-11-04
Q2 2021 $23M +$6.27M +37.4% Jun 30, 2021 6-K 2021-08-05
Q1 2021 $22.8M +$4.89M +27.2% Mar 31, 2021 6-K 2021-05-05
Q4 2020 $23.8M +$1.35M +6.02% Dec 31, 2020 20-F 2022-03-29
Q3 2020 $17.1M -$6.57M -27.7% Sep 30, 2020 6-K 2020-11-05
Q2 2020 $16.7M -$7.04M -29.6% Jun 30, 2020 6-K 2020-08-06
Q1 2020 $18M Mar 31, 2020 6-K/A 2020-05-11
Q4 2019 $22.4M -$660K -2.86% Dec 31, 2019 40-F/A 2021-03-29
Q3 2019 $23.7M Sep 30, 2019 6-K 2019-11-07
Q2 2019 $23.8M Jun 30, 2019 6-K 2019-08-13
Q4 2018 $23.1M -$1.87M -7.5% Dec 31, 2018 20-F 2020-03-31
Q4 2017 $25M -$469K -1.84% Dec 31, 2017 20-F 2019-04-01
Q4 2016 $25.4M Dec 31, 2016 20-F 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.